About Information Provided on This Site

The information provided on our website 'Kabutan.com' is not intended to constitute investment solicitation or investment advisory services.
All investment decisions should be made at your own discretion and judgment.
The data on our website is provided by Tokyo Stock Exchange, Osaka Exchange, Nagoya Securities Exchange, JPX Market Innovation & Research, Japannext, and other sources.
Copyright of the Nikkei Stock Average belongs to Nikkei Inc. Stock price charts displayed on Kabutan.com are provided solely for the purpose of reviewing historical price movements of the securities.
These charts neither suggest nor guarantee future price movements of the securities and do not constitute recommendations to buy or sell.
In our financial results coverage, the term 'Surprise Results' identifies securities that demonstrate a significant degree of surprise in their earnings announcements.
This significance is quantitatively assessed based on multiple factors, including: the nature of the announcement (full-year or quarterly results); types of revisions (earnings or dividend forecasts); and numerical analysis comparing the announced results with both the company's previous forecasts and historical performance.
The 'Surprise Ranking' presents these results in order of their calculated surprise factor. Please note that neither these results nor rankings are intended to suggest or guarantee future performance of the listed securities, nor should they be construed as recommendations to buy or sell.
minkabu the infonoid
(C) 2024 MINKABU THE INFONOID, Inc.
kabutan

SAWAI GROUP HOLDINGS Co.,Ltd.(4887) Summary

4887
TSE Prime
SAWAI GROUP HOLDINGS Co.,Ltd.
2,049.5
JPY
+8.5
(+0.42%)
Apr 30, 3:30 pm JST
14.37
USD
Apr 30, 2:30 am EDT
Result
PTS
outside of trading hours
Summary Chart Historical News Financial Result
PER
8.9
PBR
1.22
Yield
2.59%
Margin Trading Ratio
1.39
Stock Price
Apr 30, 2025
Opening Apr 30, 9:00 am
2,059.5 JPY 14.47 USD
Previous Close Apr 28
2,041.0 JPY 14.20 USD
High Apr 30, 10:15 am
2,067.0 JPY 14.52 USD
Low Apr 30, 12:44 pm
2,043.5 JPY 14.34 USD
Volume
357,200
Trading Value
0.73B JPY 5.14M USD
VWAP
2052.84 JPY 14.4 USD
Minimum Trading Value
204,950 JPY 1,437 USD
Market Cap
0.24T JPY 1.67B USD
Number of Trades
1,176
Liquidity & Number of Trades
As of Apr 30, 2025
Liquidity
High
1-Year Average
1,829
1-Year High Nov 12, 2024
7,056
Margin Trading
Date Short Interest Long Margin Positions Ratio
Apr 25, 2025 25,100 71,700 2.86
Apr 18, 2025 23,200 76,500 3.30
Apr 11, 2025 22,200 101,700 4.58
Apr 4, 2025 33,700 88,400 2.62
Mar 28, 2025 28,500 98,700 3.46
Company Profile
SAWAI GROUP HOLDINGS Co., Ltd. is a leading generic pharmaceutical company, specializing in lifestyle disease treatments and anti-cancer drugs. The company is focusing on expanding its business in the United States.
Sector
Pharmaceuticals
SAWAI GROUP HOLDINGS Co., Ltd. primarily engages in the manufacturing and sales of prescription and over-the-counter pharmaceuticals. The group consists of a holding company and eight consolidated subsidiaries, operating under a single segment of "manufacturing and sales of pharmaceuticals and related products." The core company, Sawai Pharmaceutical Co., Ltd., manufactures and sells pharmaceuticals to domestic distributors, wholesalers, other pharmaceutical manufacturers, and medical institutions. Medisa Shinyaku Co., Ltd. handles the sales of prescription drugs, while Kaken Shoyaku Co., Ltd. is responsible for the manufacturing and sales of prescription drugs and the supply of primary raw materials. Trust Pharmatech Co., Ltd. manufactures and sells prescription drugs and is entrusted with part of the research and development and manufacturing operations from Sawai Pharmaceutical. The group as a whole strives for efficient business operations and aims to strengthen its competitiveness in the pharmaceutical market.